Directory
>
Tamas Blandl
Tamas Blandl
Vice President, Manufacturing and CMC Development | Orca Bio
San Francisco, California, United States
Tamas Blandl
Summary
Tamas Blandl is a seasoned Vice President specializing in Manufacturing and CMC Development at Orca Bio, with a robust background in biopharmaceutical manufacturing. His career spans over two decades, marked by leadership roles in organizations such as Merck and NGM Biopharmaceuticals, where he successfully managed complex CMC functions and advanced clinical-stage biologics. Tamas is known for transforming technical departments and enhancing capabilities, which has led to significant improvements in operational efficiency and project delivery. He has a proven track record in process development, regulatory submissions, and cross-functional team leadership. His expertise encompasses a wide range of disciplines within life sciences, particularly in bioprocessing and monoclonal antibody production. Tamas holds a PhD in Biochemistry from the University of Notre Dame, underscoring his strong academic foundation. He is passionate about advancing biopharmaceutical innovations and is committed to driving excellence in manufacturing processes.
Tamas Blandl
Work Experience
Vice President, Manufacturing and CMC Development at
Orca Bio
March 2021 - Present
Vice President, Process Development and CMC at
NGM Biopharmaceuticals
April 2017 - October 2020
Senior Director, Biologics Technical Operations at
Medivation
January 2016 - March 2017
Director, Global Drug Substance Lead at
Merck
August 2014 - January 2016
Director, Downstream Process Development at
Merck
April 2012 - July 2014
Principal Scientist at
Boehringer Ingelheim (schweiz) Gmbh
March 2011 - March 2012
Principal Scientist at
Amgen, Inc.
April 2006 - March 2011
Senior Scientist at
Codexis, Inc.
March 2004 - March 2006
Senior Scientist at
Gryphon Therapeutics, Inc.
October 2002 - February 2004
Postdoctoral Fellow at
Genentech Foundation
September 2000 - September 2002
Tamas Blandl
Education
January 1995 - January 2000
Frequently Asked Questions about Tamas Blandl
What is Tamas Blandl email address?
Tamas Blandl's primary email address is ************@merck.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Tamas Blandl work for?
Tamas Blandl is a Vice President, Manufacturing and CMC Development at Orca Bio, a company specializing in Biological products, except diagnostic.
Where Tamas Blandl graduated from?
Tamas Blandl holds a degree in Biochemistry from University of Notre Dame.
How can I directly contact Tamas Blandl?
To contact Tamas Blandl directly, you can use the email address ************@merck.com. Complete contact information is available upon registration with Muraena.
Who is Tamas Blandl?
Tamas Blandl is a seasoned Vice President specializing in Manufacturing and CMC Development at Orca Bio, with a robust background in biopharmaceutical manufacturing. His career spans over two decades, marked by leadership roles in organizations such as Merck and NGM Biopharmaceuticals, where he successfully managed complex CMC functions and advanced clinical-stage biologics. Tamas is known for transforming technical departments and enhancing capabilities, which has led to significant improvements in operational efficiency and project delivery. He has a proven track record in process development, regulatory submissions, and cross-functional team leadership. His expertise encompasses a wide range of disciplines within life sciences, particularly in bioprocessing and monoclonal antibody production. Tamas holds a PhD in Biochemistry from the University of Notre Dame, underscoring his strong academic foundation. He is passionate about advancing biopharmaceutical innovations and is committed to driving excellence in manufacturing processes.
Tamas`s contact details
************@merck.com
*******@ngmbio.com
*****@orcabio.com
Colleagues
VP, Controller
Vice President of Engineering
Chief Commercial Officer
Executive Director, CMC Process Development
Co-Founder and CEO
Chief Medical Officer